A stable transcription factor complex nucleated by oligomeric AML1–ETO controls leukaemogenesis
about
Transcriptional network control of normal and leukaemic haematopoiesisThe Role of Histone Acetyltransferases in Normal and Malignant HematopoiesisCo-repressor CBFA2T2 regulates pluripotency and germline developmentStructure and Biophysics of CBFβ/RUNX and Its Translocation Products.BS69/ZMYND11 C-Terminal Domains Bind and Inhibit EBNA2.RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML.Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitorsMicroRNAs in hematopoietic developmentEpigenomic analysis of the HOX gene loci reveals mechanisms that may control canonical expression patterns in AML and normal hematopoietic cells.The LMO2 -25 Region Harbours GATA2-Dependent Myeloid Enhancer and RUNX-Dependent T-Lymphoid Repressor Activity.Identification of a dynamic core transcriptional network in t(8;21) AML that regulates differentiation block and self-renewal.Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression.Restoration of CCAAT enhancer binding protein α P42 induces myeloid differentiation and overcomes all-trans retinoic acid resistance in human acute promyelocytic leukemia NB4-R1 cells.JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors.LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding.Differential role of Id1 in MLL-AF9-driven leukemia based on cell of origin.New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins.The RUNX family: developmental regulators in cancer.The RUNX1-PU.1 axis in the control of hematopoiesis.A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.The AS-RBM15 lncRNA enhances RBM15 protein translation during megakaryocyte differentiation.Runx1 Structure and Function in Blood Cell Development.AML associated oncofusion proteins PML-RARA, AML1-ETO and CBFB-MYH11 target RUNX/ETS-factor binding sites to modulate H3ac levels and drive leukemogenesis.Role of RUNX1 in hematological malignancies.An Effective Strategy for Stabilizing Minimal Coiled Coil Mimetics.Developmental-stage-dependent transcriptional response to leukaemic oncogene expression.Phosphatase PRL2 promotes AML1-ETO-induced acute myeloid leukemia.Suppression of RUNX1/ETO oncogenic activity by a small molecule inhibitor of tetramerization.Acetylation and deacetylation in cancer stem-like cells.A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells.AML1/ETO trans-activates c-KIT expression through the long range interaction between promoter and intronic enhancer.Emerging Roles of MTG16 in Cell-Fate Control of Hematopoietic Stem Cells and Cancer.Protein Domain Mimics as Modulators of Protein-Protein Interactions.RUNX1 and CBFβ Mutations and Activities of Their Wild-Type Alleles in AML.RUNX1-ETO Leukemia.Methylation-associated silencing of BASP1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.Genome-wide characterization of lncRNAs in acute myeloid leukemia.Glucocorticoids Inhibit Oncogenic RUNX1-ETO in Acute Myeloid Leukemia with Chromosome Translocation t(8;21).The Co-operation of RUNX1 with LDB1, CDK9 and BRD4 Drives Transcription Factor Complex Relocation During Haematopoietic Specification.Positive Regulation of Transcription by Human ZMYND8 through Its Association with P-TEFb Complex
P2860
Q27005940-84A56090-92C6-42C7-99C1-862E264D42AEQ28088295-A41AF017-28D3-4D89-8CE7-3CB20ED8C05BQ28505594-10C4FB38-BFCC-42C2-B3E9-3DF882638A75Q30252939-3B894A50-9B93-489F-91EA-0176EFB17B8AQ30981859-39BBE948-E0CB-4976-B538-6DA9F80E0036Q33759034-2728D248-16BE-46E3-A0B2-89EF6B8C8C5AQ34658892-109E0952-6E04-4F73-B354-273607CD064BQ35134358-A830D534-EE47-4471-81CD-65D6DCB20D62Q35685082-800FBDF7-6235-4922-A2F6-FE763D2CF22FQ35687910-C0E8D261-5A57-4EEC-9264-2E7B2EB9184AQ35806108-E3BCF455-E63F-4105-84CF-794E2A730972Q35904946-243E2502-D25B-492D-B977-22D2B6ED2E87Q36140549-B0B8762F-E4B4-4DDB-B237-1C761F4F6DA3Q36199628-C61AB91B-DB4F-4B9A-9423-7A9FA139FF54Q36481117-808A9A50-B0EC-466E-AC8D-C6EFE8274173Q36897128-7CCDDD9C-BD6A-4684-8817-1901FFA3FCA9Q37679748-512027F2-CD2F-4611-BB4A-4B3973BCA6F6Q38319972-95568946-2BD1-49D0-AD27-130A7314E7EFQ38370113-929B00FD-5570-4FAF-B7A5-BF36C5E8BEC9Q38738895-0B87B34B-A8A2-435E-970B-25E109DF4F67Q38775132-15D141E0-BEA7-473F-98BC-EB93A11349A8Q38904253-F27D4503-914F-4F3A-B570-EC336D8C60E8Q39058012-44756141-8C8F-48E2-9726-FB7057B97A87Q39127024-48265942-AF4F-4107-811A-0BF18ADF40B4Q40572944-2E21AB7A-5E10-4F69-B429-DB5677D58650Q42602670-830FACAA-7CE7-49A7-93EE-9B481DBAF458Q44885193-8313BB98-AE57-43EB-8E93-5B54DF747DFDQ46856578-41A3B341-E64E-4E45-A8F7-929978BF3996Q47106297-F1D02824-3794-411E-9E1C-F6643C804F73Q47284616-6C7801B3-4CAE-4E5C-A020-903ABB10A746Q47298164-996D09A2-4405-43E1-922E-C00661B6F9D6Q48189669-844C3B6A-5B23-4BFE-86B7-4E642445A943Q48351573-A20EC874-C3FA-4597-B234-BD6192E58D4CQ51097615-8EF9B0A3-98D2-42BB-ADDC-EC9E073A43EEQ51097627-2D0BE259-19C0-45B1-9EAD-82C696573429Q52718151-D08AC633-AC84-43FD-9852-CF273FF39E78Q53190281-FC6D92D3-82FD-4420-AA6F-3DD793F86B3DQ55263355-6E456C53-E418-40C9-8B84-09AB4A5B870CQ55714869-985DE69B-4577-4083-B642-830133850649Q58726533-4859EF03-1A2B-4EEE-AE99-AB3063463B93
P2860
A stable transcription factor complex nucleated by oligomeric AML1–ETO controls leukaemogenesis
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A stable transcription factor ...... 1–ETO controls leukaemogenesis
@ast
A stable transcription factor ...... 1–ETO controls leukaemogenesis
@en
A stable transcription factor ...... 1–ETO controls leukaemogenesis
@nl
type
label
A stable transcription factor ...... 1–ETO controls leukaemogenesis
@ast
A stable transcription factor ...... 1–ETO controls leukaemogenesis
@en
A stable transcription factor ...... 1–ETO controls leukaemogenesis
@nl
prefLabel
A stable transcription factor ...... 1–ETO controls leukaemogenesis
@ast
A stable transcription factor ...... 1–ETO controls leukaemogenesis
@en
A stable transcription factor ...... 1–ETO controls leukaemogenesis
@nl
P2093
P2860
P3181
P356
P1433
P1476
A stable transcription factor ...... 1–ETO controls leukaemogenesis
@en
P2093
Ari Melnick
Robert G Roeder
Stephen D Nimer
T David Soong
Tomoyoshi Nakadai
Wei-Yi Chen
Wolfgang Fischle
Xiao-Jian Sun
P2860
P2888
P3181
P356
10.1038/NATURE12287
P407
P577
2013-08-01T00:00:00Z
P5875
P6179
1013287002